Trial Details
COMPLETEDBasic Information
| Clinical ID | c1271 |
|---|---|
| Identifier | NCT05291039 |
| Trial Title | Infliximab and Adalimumab in Inflammatory Bowel Disease Patients. |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Inflammatory Bowel Diseases |
| Interventions | DRUG: Infliximab|DRUG: Adalimumab |
Participant Information
| Sponsor | Rehab Werida |
|---|---|
| City | Cairo |
| Country/Region | Egypt |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | NA |
Time Information
| Start Date | 2022-01-01 |
|---|---|
| Primary Completion Date | 2023-03-30 |
| Completion Date | 2023-04-01 |